Continues To Grow Owing To the Increasing Rate of Needle Phobia among Individuals, the Risk of Getting Infected By the Usage of Needles

 

Needle free Injection System Market

A needle-free injection system is a popular treatment method for many diseases. These devices have been around since at least the 1980s, and they continue to remain a solid option for many medical practices. Some patients may have problems with certain brands or types of these products, which is why it's critical to ask the healthcare provider about alternative products if someone is having trouble with one that their doctor prescribed. People want to ensure that they get the best product for their needs, and that means being careful about choosing the right one for them and their treatment.

The main component in an FDA-approved needle-free injection system device is compressed gas (or solution) that's injected into the injection site. The compressed gas isn't meant to harm the patient, but rather to provide a safer, more hygienic way to administer injections. This kind of device features a reusable rubber needle that's designed in a way that allows it to be inserted into the injection site without any risks or pain involved. The idea is that the healthcare provider will be able to give a more thorough injection that will reduce the risk of infection or other complications.

Market Dynamics                                  

The main factor influencing the growth of the needle-free injection system market is the increasing cases of needle-associated injuries and rapidly growing needle phobia among adults and children. For instance, according to the United Kingdom National Health Service, needle phobia affects around 1 in 10 individuals. Approximately 22% of the adult population in the world has needle phobia. Chronic diseases such as diabetes require a daily dosage of insulin that can be self-administered through needles. This can result in health injury owing to lack of adherence and lack of confidence. The increase in research related to biologics and biosimilar is another factor estimated to propel the market growth of the needle-free injection system market. Additionally, the growing incidence of communicable diseases that can be caused by needles and the increase of the geriatric population worldwide are estimated to augment the market growth.

However, the cost of needle-free injections is the main restraining factor hindering the growth of needle-free injection systems market.

This market is distributed in five regions that include Asia-Pacific, North America, Europe, Africa, and the Middle East, and Latin America. Among these, North America is expected to a significant share of the needle-free injection system market owing to the high prevalence of chronic diseases such as cancer and diabetes in the region. For instance, according to the Centers for Disease Control and Prevention, in 2020, around 34.2 million U.S. residents were suffering from diabetes. The needle-free injection system market in the Asia Pacific is estimated to witness significant growth owing to the rise of the geriatric population in the region and favorable government health policies.

Competitive Analysis

Key players operating in the needle-free injection system market include Crossject SA, European Pharma Group, Valeritas, Inc., National Medical Products Inc., INJEX Pharma AG, PenJet Corporation, Medical International Technology, Inc., Bioject Medical Technologies Inc., PharmaJet, Zogenix, Portal Instruments, Inc., Endo International plc, and Antares Pharma, Inc.

In October 2020, PharmaJet developed a needle-free injection technology to deliver COVID-19 vaccines which were developed by the University of Cambridge. Likewise, in February 2021, Zydus Cadila developed ZyCoV-D, a DNA vaccine that can be assessed to patients through a needle-free injection system.